Sweden’s Karo acquires 10 products from LEO

2 January 2020 - Deborah Wilkes

Premium

Sweden’s Karo Pharma is acquiring a portfolio of prescription and OTC products from Danish pharmaceutical company LEO Pharma for EUR90 million (USD100 million).

Click tags below for more information on topics:

Karo Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: